<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-10054-12785</identifier><datestamp>2011-12-27T05:52:16Z</datestamp><dc:title>Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery</dc:title><dc:creator>JAIN, D</dc:creator><dc:creator>BANERJEE, R</dc:creator><dc:subject>in-vitro release</dc:subject><dc:subject>physicochemical characterization</dc:subject><dc:subject>gelatin nanoparticles</dc:subject><dc:subject>albumin nanoparticles</dc:subject><dc:subject>factorial design</dc:subject><dc:subject>carrier</dc:subject><dc:subject>biodistribution</dc:subject><dc:subject>optimization</dc:subject><dc:subject>penetration</dc:subject><dc:subject>ofloxacin</dc:subject><dc:subject>nanoparticles</dc:subject><dc:subject>protein</dc:subject><dc:subject>chitosan</dc:subject><dc:subject>solid lipid nanoparticles</dc:subject><dc:subject>ciprofloxacin hydrochloride</dc:subject><dc:description>The aim of the present study was to develop single dose delivery systems based on nanotechnology for prolonged antibiotic release in a controlled manner. Five different drug-carrier ratios of ciprofloxacin hydrochloride-loaded nanoparticles of albumin, gelatin, chitosan (CS), and lipid [solid lipid nanoparticles (SLNs)] were prepared and characterized. Average particle size was found to be in the range of 73 +/- 2 to 98 +/- 44 nm for SLNs, 140 +/- 7 to 175 +/- 24 nm for albumin nanoparticles, 143 +/- 18 to 184 +/- 27 nm for gelatin nanoparticles, and 247 +/- 48 to 322 +/- 52 nm for CS nanoparticles. A drug-to-carrier ratio of 0.5:1 was preferred for CS nanoparticles having zeta potential of &gt;20 mV and drug encapsulation of 35.01% +/- 2.66%. Similarly, 0.6:1 ratio was preferred for albumin nanoparticles with zeta potential &gt;16 mV and drug encapsulation 48.20% +/- 3.01%. Zeta potentials of gelatin nanoparticles loaded with ciprofloxacin suggested that they were unstable and prone to flocculation. SLN with 0.25:1 drug carrier ratio showed 38.71% +/- 2.38% drug entrapment and -28 +/- 1 mV surface charge. All the nanoparticles showed sustained drug release avoiding "burst effect" of the free drugs for up to 120 h for albumin nanoparticles, 96 h for CS and gelatin nanoparticles, and 80 h for SLNs. The drug release profiles followed Higuchi model. Results suggest that CS nanoparticles and SLNs can act as promising carriers for sustained ciprofloxacin release in infective conditions. (C) 2007 .</dc:description><dc:publisher>WILEY-LISS</dc:publisher><dc:date>2011-09-01T13:08:29Z</dc:date><dc:date>2011-12-26T12:59:39Z</dc:date><dc:date>2011-12-27T05:52:16Z</dc:date><dc:date>2011-09-01T13:08:29Z</dc:date><dc:date>2011-12-26T12:59:39Z</dc:date><dc:date>2011-12-27T05:52:16Z</dc:date><dc:date>2008</dc:date><dc:type>Article</dc:type><dc:identifier>JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 86B(1), 105-112</dc:identifier><dc:identifier>1552-4973</dc:identifier><dc:identifier>http://dx.doi.org/10.1002/jbm.b.30994</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/xmlui/handle/10054/12785</dc:identifier><dc:identifier>http://hdl.handle.net/10054/12785</dc:identifier><dc:language>en</dc:language></oai_dc:dc>